CBER - Office of the Center Director - Organization - Text Version
The following header reflects the organizational hierarchy.
FOOD AND DRUG ADMINISTRATION
OFFICE OF MEDICAL PRODUCTS AND TOBACCO
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH
OFFICE OF THE CENTER DIRECTOR
The following is the communication box containing information to assist anyone who may want to communicate with the depicted organization via telephone, facsimile or mail.
RKW2 Bldg Suite 7100
5515 Security Lane
Rockville, MD 20852
The following is the Food and Drug Administration, Office of Medical Products and Tobacco, Center for Biologics Evaluation and Research, Office of the Center Director organization structure depicting all the organizational structures reporting to the Office Director. These organizational structures are organized in sequential order by their assigned Standard Administrative code (Alphanumeric sequence of characters beginning with the letter D).
Each organizational component will be depicted in the following standard format:
Title of organization.
Position title of the manager.
Military rank if any, first name, middle initial if any, last name, post graduate degrees if any, and if the individual is designated as acting.
Standard Administrative code.
Karen Midthun, M.D.
Reports directly to the Office Director:
Peter W. Marks, M.D., Ph.D.
Associate Director for Medicine
Barbara D. Buch, M.D.
Associate Director for Policy
Diane M. Maloney, J.D.
Associate Director for Quality Assurance
Sheryl L. Lard-Whiteford, Ph.D.
Associate Director for Research
Carolyn A. Wilson, Ph.D.
Associate Director for Review Management
Robert A. Yetter, Ph.D.
Senior Advisor for Counterterrorism/Medical Countermeasures
Cynthia L. Kelley, M.S.
Senior Advisor for International Affairs
Joan Wilmarth Blair, M.A.
Senior Scientist for Emerging and Pandemic Threat Preparedness
David S. Cho, Ph.D.
Executive Operations Staff (DKKBA10)
Anne E. Wilcox
Approved by the FDA Reorganization Coordinator and Principal Delegation Control Officer